geneticscreeninggenetherapy 110917104755-phpapp01
TRANSCRIPT
![Page 1: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/1.jpg)
Dr. Dinesh T
Junior resident,
Department of Physiology,
JIPMER
Genetic screening &
Gene therapy
Dr sclero dinesh
![Page 2: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/2.jpg)
Introduction
![Page 3: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/3.jpg)
Genetic screening
Counseling
Gene therapy
![Page 4: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/4.jpg)
History
Technology to detect and treat inborn diseases -
1961.
1972 Friedmann and Roblin authored a paper in Science titled "Gene therapy for human genetic disease?“
The late 1980's, an international team of scientists began the project to map the human genome.
September 14, 1990 - first approved gene therapy case in the United States took place.
![Page 5: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/5.jpg)
1992 - Doctor Claudio Bordignon, Milan, Italy performed the first procedure of gene therapy using hematopoietic stem cells.
1995 DNA testing in forensic cases gains fame in the O.J. Simpson trial.
2002 - first successful gene therapy treatment for adenosine deaminase-deficiency (SCID)
2003 – at University of California, Los Angeles research team inserted genes into the brain using liposome coated in a polymer called polyethylene glycol
![Page 6: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/6.jpg)
2006 - Preston Nix from the University of Pennsylvania
School of Medicine reported on VRX496, a gene-based
immunotherapy for the treatment of human
immunodeficiency virus (HIV) that uses a lentiviral vector
for delivery of an antisense gene against the HIV
envelope
2007 – Moorfields Eye Hospital and University College
London's Institute of Ophthalmology announced the
world's first gene therapy trial for inherited retinal disease
2008 there were more than 1,200 clinically applicable
genetic tests available.
![Page 7: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/7.jpg)
Genetic screening
![Page 8: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/8.jpg)
What is genetic screening?
The newest and most sophisticated of the
techniques used to test for genetic disorders.
One of the fastest moving fields in medical science.
A technique to determine the genotype or phenotype
of an organism.
Determines risk of having or passing on a genetic
disorder.
![Page 9: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/9.jpg)
Genetic screening
Genetic screening is often used to detect faulty or
abnormal genes in an organism
Can detect some genes related to an increased
risk of cancer
Can detect some genes known to cause genetic
disorders
![Page 10: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/10.jpg)
Genetic tests
The analysis of chromosomes (DNA), proteins,
and certain metabolites in order to detect
heritable disease-related genotypes, mutations,
phenotypes, or karyotype for clinical purposes.
![Page 11: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/11.jpg)
Gene tests (also called DNA-based tests), in a
broader sense
Direct examination of the DNA molecule
Biochemical tests for such gene products as
enzymes and other proteins
Microscopic examination of stained or fluorescent
chromosomes
![Page 12: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/12.jpg)
Genetic tests
Who can order?
What are the samples needed?
How to interpret the tests?
What are all the risks?
Ethical considerations?
![Page 13: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/13.jpg)
Types of screening tests• Carrier screening
• Prenatal diagnostic testing
• Newborn screening
• Pre symptomatic testing for predicting adult-onset
disorders such as Huntington's disease
• Pre symptomatic testing for estimating the risk of
developing Adult-onset cancers and Alzheimer's disease.
• Conformational diagnosis of a symptomatic individual
• Pre implantation genetic diagnosis
• Forensic/ identity testing
• Research
• Pharmacogenomics
![Page 14: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/14.jpg)
![Page 15: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/15.jpg)
Genetic screening
Adult Polycystic Kidney Disease
Alpha-1-antitrypsin deficiency
Amyotrophic lateral sclerosis
Alzheimer's disease
Ataxia telangiectasia
Central Core Disease
Charcot-Marie-Tooth disease
Congenital adrenal hyperplasia
Cystic fibrosis
Duchenne muscular dystrophy/Becker
muscular dystrophy
Dystonia
Emanuel Syndrome
Fanconi anemia, group C
Factor V-Leiden
Fragile X syndrome
Gaucher disease
Hereditary Hemochromatosis
Huntington's disease
Hereditary nonpolyposis colon cancer
Hemophilia A and B
Inherited breast and ovarian cancer
Marfan Syndrome
Mucopolysaccharidosi
Myotonic dystrophy
Neurofibromatosis type 1
Phenylketonuria
Polycystic Kidney Disease
Prader Willi/Angelman syndromes
Sickle cell disease
Spinocerebellar ataxia, type
Spinal muscular atrophy
Tay-Sachs Disease
Thalassemias
Timothy Syndrome Galactosemia
![Page 16: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/16.jpg)
Methods for prenatal screening
Pre natal screening
Invasive
Amniocentesis Chorionic villous biopsy
Fetal blood sampling
from maternal blood
Non invasive
Ultra sonogram
Maternal serum markers
Pre implantation
![Page 17: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/17.jpg)
• Abnormal results in prenatal screening
• Previous child with a chromosome abnormality
(probability of translocation carrier in parents)
• Family history of a chromosome abnormality
• Family history of a single gene disorder
• Family history of neural tube defect or other
congenital abnormalities
Indications for prenatal diagnosis
![Page 18: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/18.jpg)
Maple Syrup Urine Disease
Congenital Adrenal Hyperplasia
Congenital Hypothyroidism
Glactosemia
Biotinidase Deficiency
Homocystinuria
Phylketonuria (PKU)
Sickle cell and Other Hemoglobinopathies
Newborn Screening Tests:
![Page 19: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/19.jpg)
Pre implantation Genetic Diagnosis
(PGD)
Pre implantation Genetic Diagnosis (PGD) uses in
vitro fertilisation (IVF) to create embryos.
Tests one or two cells from each embryo for a
specific genetic abnormality.
Identifies unaffected embryos for transfer to the
uterus.
The approach through PGD assists couples at risk of
an inherited disorder to avoid the birth of an affected
child without going through selective pregnancy
termination.
![Page 20: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/20.jpg)
Pros and cones of gene testing
• To clarify a diagnosis and direct a physician
• To avoid having children with devastating diseases
• Identify people at high risk
• Provide doctors with a simple diagnostic test
• Transforming it from a usually fatal condition to a treatable one
• Possibility of laboratory errors
• Potential for provoking anxiety, and risks for discrimination
social stigmatization could outweigh the benefits of testing
![Page 21: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/21.jpg)
Genetic counseling
![Page 22: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/22.jpg)
• The process by which
patients or relatives, at risk of
an inherited disorder, are
advised of the consequences
and nature of the disorder, the
probability of developing or
transmitting it,
•This complex process can be
seen from diagnostic (the
actual estimation of risk) and
supportive aspects.
Genetic counseling
![Page 23: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/23.jpg)
• Conception (i.e. when one or two of the parents are
carriers of a certain trait)
• During pregnancy (i.e. if an abnormality is noted on an
ultrasound or if the woman will be over 35 at delivery)
• After birth (if a birth defect is seen)
• During childhood (i.e. if the child has developmental
delay)
• During adulthood (for adult onset genetic conditions
such as Huntington’s disease or hereditary cancer
syndromes).
When can we do counseling?
![Page 24: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/24.jpg)
•The couple should be counselled by a genetic
counsellor to inform them of the test results and the
risks to the foetus.
•Providing the options open to them in
management and family planning in order to
prevent, avoid or ameliorate it.
•Autonomy of decision is crucial.
•The ethical, legal, and religious issues should be
respected.
![Page 25: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/25.jpg)
• A type of genetic test that is accessible directly to
the consumer without having to go through a
health care professional.
• A variety of DTC tests, ranging from testing for
breast cancer alleles to mutations linked to cystic
fibrosis.
• Benefits of DTC testing are the accessibility of
tests to consumers, promotion of proactive
healthcare and the privacy of genetic information.
• Risks of DTC testing are the lack of governmental
regulation and the potential misinterpretation of
genetic information.
Direct-to-Consumer (DTC) genetic testing
![Page 26: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/26.jpg)
Gene therapy
![Page 27: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/27.jpg)
Gene therapy is the replacement of faulty
genes.
Introduction of functional
genetic material into target
cells to replace or
supplement defective
genes, or to modify target
cells so as to achieve
therapeutic goals.
![Page 28: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/28.jpg)
In theory it is possible to transform either somatic
cells (most cells of the body) or cells of the germ
line (such as sperm cells, ova, and their stem cell
precursors).
![Page 29: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/29.jpg)
• All gene therapy so far in people has been
directed at somatic cells.
• Germ line engineering in humans remains only a
highly controversial prospect.
![Page 30: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/30.jpg)
For the introduced gene to be transmitted
normally to offspring, it needs not only to be
inserted into the cell, but also to be incorporated
into the chromosomes by genetic recombination
![Page 31: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/31.jpg)
Somatic Cell Therapy
This is when a gene is introduced into a
patient to help them recover from a
disease.
![Page 32: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/32.jpg)
Germ Line Therapy
Changes are made to genes that will affect
subsequent generations.
![Page 33: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/33.jpg)
Applications of Gene Therapy
Radical cure of single gene diseases e.g.
cystic fibrosis, haemoglobinopathies.
Amelioration of diseases with or without a genetic
component e.g. malignancies, neurodegenerative
diseases, infectious diseases.
![Page 34: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/34.jpg)
Gene therapy concerns
![Page 35: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/35.jpg)
Vectors in gene therapy:
Viruses
Retroviruses
Adenoviruses
Adeno-associated viruses
Envelope protein pseudotyping of viral vectors
Non-viral methods
Naked DNA
Oligonucleotides
Lipoplexes and polyplexes
Hybrid methods
![Page 36: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/36.jpg)
![Page 37: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/37.jpg)
A new gene is inserted
into an adenovirus
vector,
which is used to
introduce the modified
DNA into a
human cell. If the
treatment is successful,
the new
gene will make a
functional protein.
Gene therapy using an adenovirus vector.
![Page 38: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/38.jpg)
Non viral vectors
Un complexed plasmid DNA
DNA coated gold particles
Liposomes
DNA – protein conjugates
![Page 39: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/39.jpg)
Modes of introducing genetic material
Modes
Physical methods
Gene gun
Sonoporation
Electroporation
Hybrid methods
Chemical methods
Oligonucleotides
Lipoplexes
Dentrimers
![Page 40: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/40.jpg)
Un complexed Plasmid DNA
Purified DNA or mRNA injected directly
into tissues
Injected into muscle and skin
• Utility in immunization/ vaccination against
Infectious diseases
• Ectopic synthesis of therapeutic proteins
as erythropoietin.
![Page 41: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/41.jpg)
DNA coated Gold particles
• Plasmid DNA + Gold particles ( 1 micron india)
• “shot” into cells using electric spark or
pressurized gas – “gene gun”
• Epidermis
• Skin tumours (melanomas)
• Gene mediated immunization
![Page 42: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/42.jpg)
Liposomes
• DNA surrounded by hydrophobic molecules
• Anionic – given i.v. Targets reticuloendothelial cells of liver
• Cationic – transgene expression in most tissues if given
in afferent blood supply
• Intra airway injection or aerosol to target -lung epithelium
![Page 43: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/43.jpg)
DNA- Protein conjugates
• Cell- specific DNA delivery systems
• Utilize unique cell surface receptors on
target cells
• Chemical cross linking methods used
![Page 44: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/44.jpg)
• A normal gene may be inserted into a nonspecific location
within the genome to replace a nonfunctional gene.
• An abnormal gene could be swapped for a normal gene
through homologous recombination.
• The abnormal gene could be repaired through selective
reverse mutation, which returns the gene to its normal
function.
•The regulation (the degree to which a gene is turned on or off)
of a particular gene could be altered.
Methods
![Page 45: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/45.jpg)
• In vivo
Suspension containing vector is injected
directly into the patient either systemically (i.v.)
or directly into target tissue (e.g. malignant
tumour)
• Ex vivo
Target cells (stem cells,myoblasts,fibroblasts
etc) removed from the patient, treated with
vector and injected back into the patient
Gene Transfer techniques
![Page 46: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/46.jpg)
![Page 47: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/47.jpg)
![Page 48: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/48.jpg)
![Page 49: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/49.jpg)
Spectrum of gene expression
Gene replacement for single gene disorders
Gene repair
Gene inactivation
Ectopic synthesis of therapeutic proteins
Cancer gene therapy
![Page 50: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/50.jpg)
A) Immunodeficiency Disorders
Adenosine Deaminase Deficiency
X- linked SCID
Chronic Granulomatous disease
B) Liver Disease
Familial Hypercholesterolemia
Haemophilia A
Target diseases
![Page 51: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/51.jpg)
Hemoglobinopathies
D) Lung Diseases
• Cystic Fibrosis
• α- 1 Antitrypsin Deficiency
E) Skeletal Muscle
• Duchene Muscular Dystrophy
• Limb Girdle Muscular Dystrophy
![Page 52: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/52.jpg)
Challenges• Short-lived nature of gene therapy
• Difficult to treat multi gene or multi factorial disease
• Inserting gene into correct cells.
• Controlling gene expression. Possibility of over expression
• Damage to the host gene
• Acquirement of virulence
• Chance of inducing a tumour (insertional mutagenesis)
![Page 53: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/53.jpg)
Conclusion
![Page 54: Geneticscreeninggenetherapy 110917104755-phpapp01](https://reader036.vdocuments.mx/reader036/viewer/2022062406/55a435af1a28abff178b463a/html5/thumbnails/54.jpg)
Thank u all….